UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 


 

Date of Report (Date of earliest event reported):  May 3, 2016

 

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

1-11083

 

04-2695240

(State or other

 

(Commission

 

(IRS employer

jurisdiction of

 

file number)

 

identification no.)

incorporation)

 

 

 

 

 

300 Boston Scientific Way, Marlborough, Massachusetts

 

01752-1234

(Address of principal executive offices)

 

(Zip code)

 

Registrant’s telephone number, including area code:        (508) 683-4000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 5.07.                               SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

(a)                                 Boston Scientific Corporation (the “Company”) held its 2016 Annual Meeting of Stockholders (the “Annual Meeting”) on May 3, 2016 at its Corporate Headquarters located in Marlborough, Massachusetts.

 

(b)                                 The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

 

(1)                     All ten director nominees were elected to the Company’s Board of Directors for a one-year term to hold office until the Company’s 2017 Annual Meeting of Stockholders and until their successors have been elected and qualified.

 

Nominee

 

For

 

Withheld

 

Broker Non-Votes

 

Nelda J. Connors

 

1,151,946,152

 

8,629,502

 

43,636,373

 

Charles J. Dockendorff

 

1,156,620,905

 

3,954,749

 

43,636,373

 

Donna A. James

 

1,153,330,194

 

7,245,460

 

43,636,373

 

Kristina M. Johnson

 

1,154,560,126

 

6,015,528

 

43,636,373

 

Edward J. Ludwig

 

1,155,911,759

 

4,663,895

 

43,636,373

 

Stephen P. MacMillan

 

1,154,860,449

 

5,715,205

 

43,636,373

 

Michael F. Mahoney

 

1,132,614,022

 

27,961,632

 

43,636,373

 

David J. Roux

 

1,156,601,350

 

3,974,304

 

43,636,373

 

John E. Sununu

 

1,151,623,301

 

8,952,353

 

43,636,373

 

Ellen M. Zane

 

1,155,192,940

 

5,382,714

 

43,636,373

 

 

(2)                     The advisory vote on the compensation for the Company’s “Named Executive Officers” as disclosed in the Company’s proxy statement for the Annual Meeting was approved.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

1,136,606,297

 

22,065,702

 

1,903,655

 

43,636,373

 

 

(3)                     The material terms of the performance goals under the Company’s 2011 Long-Term Incentive Plan for purposes of Section 162(m) of the Internal Revenue Code were re-approved.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

1,102,280,765

 

19,967,822

 

38,327,067

 

43,636,373

 

 

(4)                     The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2016 fiscal year was ratified.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

1,193,251,708

 

10,238,194

 

722,125

 

N/A

 

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BOSTON SCIENTIFIC CORPORATION

 

 

 

 

Date:  May 5, 2016

By:

/s/ Vance R. Brown

 

Vance R. Brown

 

Vice President and Chief Corporate Counsel

 

3